Alaxia's website is currently under maintenance. We should be back shortly. Thank you for your patience.


A private company incorporated in 2008 with strong skills and multiple patents owned


Lyon based, Infectious diseases worldwide excellence pole location


Partnership with recognized top EU and US research centers




One aim


Development of medicinal products for respiratory diseases


1st product of the pipeline coming from our peroxidase platform :       ALX-009

( Meveol®  )


Treatment of Cystic Fibrosis



ALAXIA SAS on LinkedIn

Development of a treatment to fight against Cystic Fibrosis
The regulatory preclinical study was co-financed by E.U. Europe is moving in Rhone Alpes with the European Regional Development Fund.